Neuromedical
Non-invasive vagus nerve stimulation for Alzheimer's treatment.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
* | PLN3.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Neuromedical is a Polish-Israeli research and development company focused on creating treatments for Alzheimer's disease. The company was registered in December 2016. The company's flagship product is the VGuard system, a non-invasive device for home use that stimulates the vagus nerve during sleep. This system utilizes ear-clip electrodes, a pulse generator, and adaptive algorithms to activate neuromodulators and engage cortical networks responsible for memory consolidation.
The VGuard technology was developed in Israel by Dr. Tamir Ben David, an inventor with extensive experience in medical device development and over 90 patent applications. The project was brought to Poland by Dr. Adam Broncel, a neurologist who oversees the clinical aspects. Dr. Broncel, the company's CEO/CMO, is a graduate of the Medical University of Lodz and has led R&D projects focused on Vagus Nerve Stimulation (VNS) for treating Alzheimer's. The team also includes Professor Jan Konopacki, an expert in neurophysiology, and Agnieszka Jarecka, who has over a decade of experience managing international R&D projects. The CEO is listed as Ehud Raivitz.
Neuromedical targets patients with mild cognitive impairment (MCI) or early-stage Alzheimer's, aiming to slow cognitive decline and delay the loss of independence. The business model appears to be centered on the development and sale of the VGuard medical device. The company has secured funding through several rounds, including PLN 1 million from Innoventure via the BRIdge Alfa program and a PLN 3 million seed round from the Hard2beat fund. Clinical studies involving 51 patients have shown statistically significant improvements on the ADAS-Cog scale, confirming the therapy's potential effectiveness.
Keywords: Alzheimer's treatment, neurodegenerative disease, vagus nerve stimulation, VNS, medical device, cognitive impairment, memory consolidation, neurostimulation, deep tech, clinical research, Polish-Israeli startup, VGuard system, neuromodulation, mild cognitive impairment, home medical device, electroceuticals, brain health, cognitive decline, memory enhancement, neurotechnology